Science ❯ Medical Research ❯ Clinical Trials

Drug Efficacy

Neurological Disorders Health Outcomes Ivermectin Studies RAS Mutations Long-acting Treatments GLP-1 Receptor Agonists Cardiovascular Disease Research GLP-1 Injections Neuroscience Alzheimer's Research GLP-1 Research HIV Research Cytosinicline Preventive Medicine Weight Loss Treatments Public Health Impacts AI in Research Side Effects of Medications Immunology Safety Assessments HIV Treatment Innovations Weight Loss Mechanisms Health Risks Public Health

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

Targeting mutant KRAS through cyclophilin A, the pill has been made available under an FDA expanded access pathway pending formal review.

Ivermectin Combo Prescriptions Jump After Mel Gibson Podcast, Study Finds

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler